Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
7.22
0.00 (0.00%)
Sep 16, 2025, 12:06 PM EDT - Market open
Treace Medical Concepts Revenue
Treace Medical Concepts had revenue of $47.39M in the quarter ending June 30, 2025, with 6.60% growth. This brings the company's revenue in the last twelve months to $213.75M, up 7.67% year-over-year. In the year 2024, Treace Medical Concepts had annual revenue of $209.36M with 11.89% growth.
Revenue (ttm)
$213.75M
Revenue Growth
+7.67%
P/S Ratio
2.11
Revenue / Employee
$448,115
Employees
477
Market Cap
456.11M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 209.36M | 22.24M | 11.89% |
Dec 31, 2023 | 187.12M | 45.28M | 31.92% |
Dec 31, 2022 | 141.84M | 47.42M | 50.22% |
Dec 31, 2021 | 94.42M | 37.05M | 64.59% |
Dec 31, 2020 | 57.37M | 17.95M | 45.54% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
TMCI News
- 6 days ago - Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2025 American Orthopaedic Foot & Ankle Society Annual Meeting - GlobeNewsWire
- 12 days ago - Treace Medical Concepts, Inc. (TMCI) Investor Day 2025 Call Transcript - Seeking Alpha
- 5 weeks ago - Treace Medical Concepts, Inc. (TMCI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Treace Medical Concepts Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Treace Medical to Host Investor Day Highlighting New Products on September 3, 2025 - GlobeNewsWire
- 2 months ago - Notice to Long-Term Shareholders of Maison Solutions Inc. (NASDAQ: MSS); Napco Security Technologies, Inc. (NASDAQ: NSSC); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NYSE: VIRT): Grabar Law Office is Investigating Claims on Yo - GlobeNewsWire
- 3 months ago - TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm - PRNewsWire
- 3 months ago - Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology - GlobeNewsWire